The Possible Importance of 3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia

被引:35
|
作者
Johansen, Silje [1 ]
Brenner, Annette K. [1 ,2 ]
Bartaula-Brevik, Sushma [2 ]
Reikvam, Hakon [1 ,2 ]
Bruserud, Oystein [1 ,2 ]
机构
[1] Haukeland Hosp, Dept Med, Sect Hematol, N-5021 Bergen, Norway
[2] Univ Bergen, Inst Clin Sci, Sect Hematol, N-5007 Bergen, Norway
关键词
acute myeloid leukemia; integrin; beta3; ACUTE MYELOGENOUS LEUKEMIA; FOCAL ADHESION KINASE; MESENCHYMAL STROMAL CELLS; TISSUE GROWTH-FACTOR; PROGNOSTIC-FACTOR; STEM-CELLS; GENE-EXPRESSION; LIGAND-BINDING; PROTEIN; AML;
D O I
10.3390/ijms19010251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute myeloid leukemia (AML) is an aggressive bone marrow malignancy where the immature leukemia cells communicate with neighboring cells through constitutive cytokine release and through their cell surface adhesion molecules. The primary AML cells express various integrins. These heterodimeric molecules containing an and a chain are cell surface molecules that bind extracellular matrix molecules, cell surface molecules and soluble mediators. The 3 integrin (ITGB3) chain can form heterodimers only with the two chains IIb and V. These integrins are among the most promiscuous and bind to a large number of ligands, including extracellular matrix molecules, cell surface molecules and soluble mediators. Recent studies suggest that the two 3 integrins are important for leukemogenesis and chemosensitivity in human AML. Firstly, IIb and 3 are both important for adhesion of AML cells to vitronectin and fibronectin. Secondly, 3 is important for the development of murine AML and also for the homing and maintenance of the proliferation for xenografted primary human AML cells, and for maintaining a stem cell transcriptional program. These last effects seem to be mediated through Syk kinase. The 3 expression seems to be regulated by HomeboxA9 (HoxA9) and HoxA10, and the increased 3 expression then activates spleen tyrosine kinase (Syk) and thereby contributes to cytokine hypersensitivity and activation of 2 integrins. Finally, high integrin V/3 expression is associated with an adverse prognosis in AML and decreased sensitivity to the kinase inhibitor sorafenib; this integrin can also be essential for osteopontin-induced sorafenib resistance in AML. In the present article, we review the experimental and clinical evidence for a role of 3 integrins for leukemogenesis and chemosensitivity in AML.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Decitabine for acute myeloid leukemia
    Marks, Peter W.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) : 299 - 305
  • [22] Genomics of Acute Myeloid Leukemia
    Graubert, Timothy A.
    Mardis, Elaine R.
    CANCER JOURNAL, 2011, 17 (06) : 487 - 491
  • [23] The roles and mechanisms of TGFB1 in acute myeloid leukemia chemoresistance
    Liang, Xue
    Zhou, Ji
    Li, Cong
    Wang, Huiping
    Wan, Yang
    Ling, Chun
    Pu, Lianfang
    Zhang, Wanqiu
    Fan, Mengmeng
    Hong, Jingfang
    Zhai, Zhimin
    CELLULAR SIGNALLING, 2024, 116
  • [24] Acute myeloid leukemia stem cells: seek and destroy
    Roboz, Gail J.
    Guzman, Monica
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) : 663 - 672
  • [25] A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia
    Bi, Laixi
    Zhou, Bin
    Li, Haiying
    He, Licai
    Wang, Chunjing
    Wang, Zhonggai
    Zhu, Liqing
    Chen, Mengqian
    Gao, Shenmeng
    BMC CANCER, 2018, 18
  • [26] Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
    Wakita, Satoshi
    Marumo, Atsushi
    Morita, Kaoru
    Kako, Shinichi
    Toya, Takashi
    Najima, Yuho
    Doki, Noriko
    Kanda, Junya
    Kuroda, Junya
    Mori, Shinichiro
    Satake, Atsushi
    Usuki, Kensuke
    Ueki, Toshimitsu
    Uoshima, Nobuhiko
    Kobayashi, Yutaka
    Kawata, Eri
    Nakayama, Kazutaka
    Nagao, Yuhei
    Shono, Katsuhiro
    Shibusawa, Motoharu
    Tadokoro, Jiro
    Hagihara, Masao
    Uchiyama, Hitoji
    Uchida, Naoyuki
    Kubota, Yasushi
    Kimura, Shinya
    Nagoshi, Hisao
    Ichinohe, Tatsuo
    Kurosawa, Saiko
    Motomura, Sayuri
    Hashimoto, Akiko
    Muto, Hideharu
    Sato, Eriko
    Ogata, Masao
    Mitsuhashi, Kenjiro
    Ando, Jun
    Tashiro, Haruko
    Sakaguchi, Masahiro
    Yui, Shunsuke
    Arai, Kunihito
    Kitano, Tomoaki
    Miyata, Miho
    Arai, Haruka
    Kanda, Masayuki
    Itabashi, Kako
    Fukuda, Takahiro
    Kanda, Yoshinobu
    Yamaguchi, Hiroki
    CANCER SCIENCE, 2023, 114 (04) : 1297 - 1308
  • [27] Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
    Hatzl, Stefan
    Perfler, Bianca
    Wurm, Sonja
    Uhl, Barbara
    Quehenberger, Franz
    Ebner, Susanne
    Troppmair, Jakob
    Reinisch, Andreas
    Woelfler, Albert
    Sill, Heinz
    Zebisch, Armin
    CANCERS, 2020, 12 (02)
  • [28] Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia
    Aasebo, Elise
    Bartaula-Brevik, Sushma
    Hernandez-Valladares, Maria
    Bruserud, Oystein
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (01) : 13 - 24
  • [29] Venetoclax Resistance in Acute Myeloid Leukemia
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Collette, Yves
    Vey, Norbert
    CANCERS, 2024, 16 (06)
  • [30] Targeted immunotherapy for acute myeloid leukemia
    Vasu, Sumithira
    Caligiuri, Michael A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (04) : 533 - 540